ZNTL 424B5: Secondary offering
Filed with the SEC on · accession 0001628280-26-057108
ZNTL filed a 424B5 (prospectus (offering)) with the SEC on Aug 14, 2026. The final terms of an offering of shares or bonds. The stock moved -14.2% by the first close after the filing.
Summary of the filing
Zentalis Pharmaceuticals is offering 23,000,000 shares of common stock at a public offering price of $3.50 per share, with an option for underwriters to purchase an additional 3,450,000 shares, expecting total gross proceeds of $80.5 million.
Key details
How ZNTL stock reacted
Close before
$4.15
Aug 13, 2026
First close after
-14.22%
$3.56
5 trading days
-7.47%
$3.84
Since filing
-58.55%
$1.72
✦ Ask GOAX AI about this filing — what it means for ZNTL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ZNTL?
Click hereFrequently asked questions
What did ZNTL file with the SEC on Aug 14, 2026?
ZNTL filed a 424B5 (Secondary offering). Zentalis Pharmaceuticals is offering 23,000,000 shares of common stock at a public offering price of $3.50 per share, with an option for underwriters to purchase an additional 3,450,000 shares, expecting total gross proceeds of $80.5 million.
What does a secondary offering mean for ZNTL stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did ZNTL stock react to this filing?
ZNTL closed at $4.15 before the filing and $3.56 on Aug 14, 2026 (-14.22%). Five trading days later: $3.84 (-7.47%).
Other ZNTL SEC filings
- SCHEDULE 13G/A · SEC filingOct 27, 2026
- SCHEDULE 13G/A · SEC filingAug 19, 2026
- 8-K · Secondary offeringAug 14, 2026
- 424B5 · Secondary offeringAug 13, 2026
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingJun 18, 2026
- 8-K · SEC filingMay 27, 2026
- 8-K · Fda approvalMay 21, 2026
Get alerts when ZNTL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days